Phase I Clinical Study of SHR-5495 in the Treatment of Patients With Advanced Malignant Tumors

NCT06059508 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignant Tumor

Interventions

DRUG: SHR-5495 for injection

Sponsor

Suzhou Suncadia Biopharmaceuticals Co., Ltd.